The Construction and Design Division (CONDES) serves practitioners in all areas of automation, bringing together professionals involved in design, construction, and commissioning activities related to all types of facilities. CONDES supports development of applicable standards, recommended practices, and technical papers. Within the construction and design arenas, Division Members are involved in all facets of facility design and construction, building automation, safety and security, construction management, and commissioning of facilities and process systems.
News Update (January 2021):After being dormant for several years, we are pleased to announce that our Construction and Design Technical Division is now active again!
We have a new group of enthusiastic volunteer leaders, and great plans for 2021. We invite you to read our new quarterly newsletter and stay tuned for ISAConnect Live virtual meetings planned in 2021.
Newsletters
"TBD" Wednesday, TBD, 2021 10:00 am ET (UTC-4:00)
Register in advance for this meeting:
Icebreaker Reactor Approved for Ground-Based Nuclear Plant
South Africa Nuclear Regulator Furthers New Nuclear Build Process
Fuel Loading Only Major Milestone Left for Vogtle Unit 3 Nuclear Project
Exelon Set to Decommission Illinois Nuclear Plants
El Dabaa First of ‘Several’ Nuclear Reactors for Egypt
Nuclear First—Work Starts on Russian Fast Neutron Reactor
Wyoming Coal Power Plant May Host Natrium Advanced Nuclear Demonstration
USNC’s MMR Project Becomes First SMR in Canada to Enter Formal Licensing Phase
NuScale Exploring Marine-Deployed SMR Power Plant
Norwegian Wind Farm Presents Construction, Operational Challenges
Merck Invests €250 Million in Production Value Chain in China
Sanofi and Lonza to Build New US$285 million Swiss Biologics Facility
Merck MilliporeSigma Opens its First BioReliance® End-to-End Biodevelopment Center in China
Sanofi to Invest US$410 million in State-of-the-Art Vaccine Facility at Canada
WuXi Biologics Plans to Invest US$ 382 million to Build Largest Biomanufacturing Facility Centre in Ireland
Merck Announces its Plans to Invest US$1.12 billion at the Darmstadt Site until 2025
Mapi Pharma to Build a New Sterile Injectable Production Plant in Jerusalem
PCI Pharma Services Starts Expansion of its Tredegar Facility in UK
Eli Lilly to Invest US$470million for Pharmaceutical Plant Construction
Astellas to Construct New Pharma Manufacturing Facility in Japan
Evonik Expands Dossenheim and Hanau Sites in Germany
Thermo Fisher Scientific Plans to Expand New Facility in Singapore
SeqirusConstructs World Class Vaccine Manufacturing Facility in Australia
Get involved in ISA Standards:ISA S 105 Standard Committee & IEC 62381 FAT, SAT, & SIT & IEC 62382 E&I Loop Checks
ISA105, Commissioning, Loop Checks, and Factory & Site Acceptance/In - ISA Connect
ISA105, Commissioning, Loop Checks,&Factory Tests-ISA
For more information: visit https://www.isa.org/isa105/
Connect to the ISA S 105 Standard - Commissioning Listserve
DIRECTORS' MESSAGES
2017 Directors' Message
Division Documents:
Division Annual ReportDivision Budget & Business Plan